ODDB.org: Open Drug Database

Home - 59219 - 02 - 002

Irinotecan Orion 100 mg/5 ml, Infusionskonzentrat - Durchstechflasche(n)

Swissmedic Key	59219002	Registration Holder	Orion Pharma AG
Name	Irinotecan Orion 100 mg/5 ml, Infusionskonzentrat	Date of registration	11.09.2009
		Introduction of Sequence	11.09.2009
ATC-Classification	Irinotecan (L01XX19)	Revision date
WHO	WHO-DDD	Valid until	10.09.2019
Index Therapeuticus (BSV)	07.16.10.	Show package size	Durchstechflasche(n)
Index Therapeuticus (Swissmedic)	07.16.10.	Description
Swissmedic categorie.	A
SL Eintrag	No	Indication
Information for professionals	IP	Consumer information
Ex-factory-Price	107.87
Deductible	k.A.	Consumer price	140.25
Feedback	FB
GTIN	7680592190025	Medication Code	Synthetika human
Pharmacode		Disponibility

Composition

irinotecani hydrochloridum trihydricum 100 mg, sorbitolum, acidum lacticum, aqua ad iniectabilia q.s. ad solutionem pro 5 ml.

Packungsbestandteile

Galenic Form	Concentrate for infusion

Source

Data was imported : 03.09.2014 Swissmedic Registration : 59219 Sequence : 02 Product name : Irinotecan Orion 100 mg/5 ml, Infusionskonzentrat Registration owner: : Orion Pharma AG Product group : Index Therapeuticus (BSV) : 07.16.1. Medication Code : Synthetika human Date of registration : 11.09.2009 Valid until : 10.09.2019 Package number : 002 Show package size : 1 Commercial Form/Unit : Durchstechflasche(n) Swissmedic categorie. : A Active Agents : irinotecani hydrochloridum trihydricum Composition : irinotecani hydrochloridum trihydricum 100 mg, sorbitolum, acidum lacticum, aqua ad iniectabilia q.s. ad solutionem pro 5 ml.

2025	©ywesee GmbH